Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01794936 · ClinicalTrials.gov registry record · NA

Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery

A NA study, sponsored by Columbia University.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT01794936: Clinical Trial NA study, sponsored by Columbia University.

NCT01794936 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01794936, a NA study, was terminated before completion, sponsored by Columbia University.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

This study is designed to evaluate the use of a disposable laparoscopic Doppler probe in robotic assisted prostatectomies. The Vascular Technology, Inc. (VTI) laparoscopic probe is simply a sterile, disposable Doppler probe that can be inserted through a laparoscopic trocar and placed on structures to determine if there is vascular flow demonstrating an audible pulse. During robotic-assisted prostatectomy, identification of vasculature is critical in order to prevent hemorrhage and effectively treat the underlying pathology. The investigators routinely utilize a combined Doppler ultrasound laparoscopic probe to identify vasculature during renal surgery, but Doppler ultrasound usage has not been adopted for prostatic surgery. From a mechanical standpoint, these combination probes differ from the VTI probe in that they are approximately 2 times the diameter of the VTI probe, and the portion of the probe utilized for imaging much longer and on the side of the device. The VTI probe is much narrower, and the portion of the probe utilized for vessel identification is at the tip of the probe. For robotic-assisted prostatectomy, patients will be randomized to VTI laparoscopic Doppler System to identify pedicles and neurovascular bundles (NVB) or to robotic-assisted laparoscopic prostatectomy with no Doppler probe, which is the current standard of care.

Primary Outcome

Patients are to be evaluated for erectile function at 8 month post-operative visit using validated SHIM questionnaire.

Interventions

  • DEVICE VTI Probe

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2011-08
Est. Completion 2012-04
Phase NA
Columbia University

958 total trials

Why NCT01794936 stopped before completion

NCT01794936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which VTI Probe is the first listed.

NCT01794936 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01794936 about?

NCT01794936 is a clinical study titled "Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery". This study is designed to evaluate the use of a disposable laparoscopic Doppler probe in robotic assisted prostatectomies. The Vascular Technology, Inc. (VTI) laparoscopic probe is simply a sterile, disposable Doppler probe that can be inserted through a laparoscopic trocar and placed on structures ...

What is the current status of trial NCT01794936?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2011-08. Estimated completion is 2012-04.

What interventions are being tested in trial NCT01794936?

The interventions under investigation include: VTI Probe (DEVICE).

Who is sponsoring clinical trial NCT01794936?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01794936's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01794936, the US trial registry maintained by the National Library of Medicine. NCT01794936 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.